Will deeper characterization of the landscape of immune checkpoint molecules in acute myeloid leukemia bone marrow lead to improved therapeutic targeting?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30861094.
- Also identified by DOI 10.1002/cncr.32042 and PMC identifier 6467744.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
T cells in the bone marrow from patients with acute myeloid leukemia have increased expression of several immune checkpoint molecules. Can this knowledge be translated to novel therapeutic strategies?
Medical subject headings
- Bone Marrow
- Leukemia, Myeloid, Acute